Evidence map›Paper›PMID 42710267›Full record

ArticleNeoplasia (New York, N.Y.)2026

Glioblastoma recurrence: An NGS-centered seed-soil framework.

Jun-Yi Xu, Jingxian Chen, Wenyan Feng, Guo-Zhong Yi

Abstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jun-Yi XuSchool of Public Health, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Jingxian ChenSchool of Public Health, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Wenyan FengDepartment of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangdong, 510515, China.
Guo-Zhong YiDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China; Nanfang Glioma Center, Guangzhou, Guangdong, 510515, China; Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China. Electronic address: yiguozhong09@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrence of IDH-wild-type glioblastoma (GBM) remains the major obstacle to improving patient survival. Current recurrence models emphasize tumor-intrinsic mechanisms, including therapeutic resistance, cellular plasticity, and clonal evolution, but do not fully explain how residual tumor cells reconstruct recurrent disease after surgery. Here, we propose an NGS-centered seed-soil framework that considers surgical resection as the starting point of recurrence evolution: residual NEU/OPC/NPC-like tumor cells represent potential recurrence "seed", the postsurgical brain constitutes a dynamically remodeled "soil", and neuron-glioma synapse (NGS) provides a potential interface between residual tumor cells and neurons of this environment. At the recurrence endpoint, recurrent GBM exhibits enhanced neuronal and NGS-associated characteristics, providing an observable phenotype with which this framework can be evaluated. We then examine the potential processes linking these two states, including therapy-associated NGS remodeling, NGS-associated network reconstruction, and neuronal-like migration, which may contribute to the development of local and distant recurrence. Throughout, established observations are distinguished from hypothesis-driven interpretations and untested predictions. Finally, we discuss critical experimental requirements, including longitudinal post-resection models and NGS-specific perturbation, as well as emerging translational opportunities such as neuromodulation and perioperative intervention. This framework shifts the perspective on GBM recurrence from residual tumor-cell survival alone toward dynamic interactions between residual tumor cells and the postsurgical neural environment.

Indexed as

Cancer neuroscienceGlioblastomaNeuron-glioma synapsePostsurgical marginRecurrence

Identifiers

PMID42710267
PMCPMC13573690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.